Asthma and COPD Inhalers That Contain Ozone-depleting CFCs to be Phased Out; Alternative Treatments Available

Links shared publicly online about this topic.

  • 1,212
    total visits

Asthma and COPD Inhalers That Contain Ozone-depleting CFCs to be Phased Out; Alternative Treatments Available

dld.bz

The U.S. Food and Drug Administration today announced, in accordance with longstanding U.S. obligations under the Montreal Protocol on Substances that Deplete the Ozone Layer, seven metered-dose inhalers (MDI) used to treat asthma and chronic obstructive pulmonary disease (COPD) will be gradually removed from the U.S. marketplace. These inhalers contain ozone-depleting chlorofluorocarbons (CFCs), which are propellants that move medication out of the inhaler and into the lungs of patients. Altern

View full resource at dld.bz

Tags: Asthma, COPD, Diet and Nutrition, Drug, FDA, Pulmonology

  • Share

Most Recently Shared on April 26, 2010 at 3:01 pm By:

drchacko Northside Allergy

Great tie into last week's earth day: FDA to remove asthma inhalers that deplete the Ozone layer.---> http://dld.bz/bvTh. Pls RT

2 years ago...

Asthma and COPD Inhalers That Contain Ozone-depleting CFCs to be Phased Out; Alternative Treatments Available - Drugs.com MedNews

drugs.com — “Asthma and COPD Inhalers That Contain Ozone-depleting CFCs to be Phased Out Alternative Treatments Available The U.S. Food and Drug Administration today announcView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on April 14, 2010 at 11:08 pm By:

drugscom Drugs.com Health Site

Asthma and COPD Inhalers That Contain Ozone-depleting CFCs to be Phased Out - http://bit.ly/cxfAoj

2 years ago...

Asthma and COPD Inhalers That Contain Ozone-depleting CFCs to be Phased Out; Alternative Treatments Available

fda.gov — “The U.S. Food and Drug Administration today announced, in accordance with longstanding U.S. obligations under the Montreal Protocol on Substances that Deplete the Ozone Layer, seven metered-dose inhalers (MDI) used to treat asthma and chronic obstructive pulmonary disease (COPD) will be gradually removed from the U.S. marketplace. These inhalers contain ozone-depleting chlorofluorocarbons (CFCs), which are propellants that move medication out of the inhaler and into the lungs of patients. AlternView full resource at fda.gov

  • View Related
  • Share

Most Recently Shared on April 13, 2010 at 8:40 pm By:

eyeonfda eyeonfda Health Lawyer and Pharma

FDA - Asthma and COPD Inhalers That Contain Ozone-depleting CFCs to be Phased Out http://ow.ly/1y46M

2 years ago...

Advertisement